Our data as well as a recent study using several human cell lines show high sensitivity of AML cells towards dual CDK12/13 inhibition, suggesting that CDK12 might be a more broadly relevant target for hematologic malignancies56. The gene discussed is CDK12; the disease is acute myeloid leukemia.